Trials / Active Not Recruiting
Active Not RecruitingNCT06038474
Descartes-08 for Patients With Systemic Lupus Erythematosus
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Cartesian Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase II study to evaluate the safety, tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic Lupus erythematosus (SLE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Descartes-08 | Autologous T-cells expressing a chimeric antigen receptor directed to BCMA |
Timeline
- Start date
- 2024-02-12
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2023-09-14
- Last updated
- 2026-03-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06038474. Inclusion in this directory is not an endorsement.